{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "B.1.1.7 lineage",
      "COVID-19 pandemic",
      "SARS CoV-2",
      "SYBR Green-based RT-PCR",
      "VOC (202012/01)"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34613565",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "01",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "10",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s11033-021-06717-y"
    ],
    "Journal": {
      "ISSN": "1573-4978",
      "JournalIssue": {
        "Volume": "48",
        "Issue": "11",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov"
        }
      },
      "Title": "Molecular biology reports",
      "ISOAbbreviation": "Mol Biol Rep"
    },
    "ArticleTitle": "A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR.",
    "Pagination": {
      "StartPage": "7243",
      "EndPage": "7249",
      "MedlinePgn": "7243-7249"
    },
    "Abstract": {
      "AbstractText": [
        "The new SARS-CoV-2 variant VOC (202012/01), identified recently in the United Kingdom (UK), exhibits a higher transmissibility rate compared to other variants, and a reproductive number 0.4 higher. In the UK, scientists were able to identify the increase of this new variant through the rise of false negative results for the spike (S) target using a three-target RT-PCR assay (TaqPath kit).",
        "To control and study the current coronavirus pandemic, it is important to develop a rapid and low-cost molecular test to identify the aforementioned variant. In this work, we designed primer sets specific to the VOC (202012/01) to be used by SYBR Green-based RT-PCR. These primers were specifically designed to confirm the deletion mutations \u039469/\u039470 in the spike and the \u0394106/\u0394107/\u0394108 in the NSP6 gene. We studied 20 samples from positive patients, detected by using the Applied Biosystems TaqPath RT-PCR COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. 16 samples displayed an S-negative profile (negative for S target and positive for N and ORF1ab targets) and four samples with S, N and ORF1ab positive profile.",
        "Our results emphasized that all S-negative samples harbored the mutations \u039469/\u039470 and \u0394106/\u0394107/\u0394108. This protocol could be used as a second test to confirm the diagnosis in patients who were already positive to COVID-19 but showed false negative results for S-gene.",
        "This technique may allow to identify patients carrying the VOC (202012/01) or a closely related variant, in case of shortage in sequencing."
      ],
      "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive licence to Springer Nature B.V."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Molecular Biology and Cancer Immunology (Covid 19 Unit), Faculty of Science I, Lebanese University, Hadath, Beirut, 1003, Lebanon."
          }
        ],
        "LastName": "Abdel Sater",
        "ForeName": "Fadi",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Department, Beirut Cardiac Institute, Old Airport Road, Beirut, Lebanon."
          }
        ],
        "LastName": "Younes",
        "ForeName": "Mahmoud",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bahman Hospital, Beirut, Lebanon."
          }
        ],
        "LastName": "Nassar",
        "ForeName": "Hassan",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Parasitology, ISTUN Instituto de Salud Tropical, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/ Irunlarrea 1, 31008, Pamplona, Navarra, Spain. panguewa@unav.es."
          }
        ],
        "LastName": "Nguewa",
        "ForeName": "Paul",
        "Initials": "P"
      },
      {
        "Identifier": [
          "0000-0001-6740-4817"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Molecular Biology and Cancer Immunology (Covid 19 Unit), Faculty of Science I, Lebanese University, Hadath, Beirut, 1003, Lebanon. kassem.hamze@ul.edu.lb."
          }
        ],
        "LastName": "Hamze",
        "ForeName": "Kassem",
        "Initials": "K"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Validation Study"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Mol Biol Rep",
    "NlmUniqueID": "0403234",
    "ISSNLinking": "0301-4851"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Benzothiazoles"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "DNA Primers"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Diamines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Fluorescent Dyes"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Quinolines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "163795-75-3",
      "NameOfSubstance": "SYBR Green I"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Mol Biol Rep. 2022 Apr;49(4):3365",
      "PMID": "34977991"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Benzothiazoles"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Costs and Cost Analysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "DNA Primers"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diamines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Fluorescent Dyes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quinolines"
    },
    {
      "QualifierName": [
        "economics",
        "methods"
      ],
      "DescriptorName": "Real-Time Polymerase Chain Reaction"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ],
  "CoiStatement": "The authors declare that they have no competing interests."
}